UnitedHealth Group Incorporated (UNH)
USD 425.5
(-0.57%)
USD 425.5
(-0.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 36.33 Billion USD | 8.17% |
| 2022 | 31.83 Billion USD | 20.43% |
| 2021 | 27.07 Billion USD | 4.01% |
| 2020 | 25.29 Billion USD | 6.2% |
| 2019 | 22.4 Billion USD | 13.32% |
| 2018 | 19.77 Billion USD | 13.28% |
| 2017 | 17.45 Billion USD | 13.82% |
| 2016 | 14.98 Billion USD | 20.62% |
| 2015 | 12.71 Billion USD | 8.19% |
| 2014 | 11.75 Billion USD | 6.86% |
| 2013 | 10.99 Billion USD | 4.12% |
| 2012 | 10.56 Billion USD | 10.17% |
| 2011 | 9.58 Billion USD | 7.39% |
| 2010 | 8.92 Billion USD | 21.47% |
| 2009 | 7.35 Billion USD | 17.71% |
| 2008 | 6.24 Billion USD | -27.77% |
| 2007 | 8.64 Billion USD | 27.45% |
| 2006 | 7.65 Billion USD | 27.33% |
| 2005 | 5.53 Billion USD | 30.34% |
| 2004 | 4.47 Billion USD | 37.29% |
| 2003 | 2.97 Billion USD | 21.96% |
| 2002 | 2.44 Billion USD | 33.32% |
| 2001 | 1.83 Billion USD | 28.94% |
| 2000 | 1.44 Billion USD | 20.75% |
| 1999 | 38.41 Billion USD | -26.18% |
| 1998 | 868 Million USD | 79.39% |
| 1997 | 888 Million USD | 14.66% |
| 1996 | 744.54 Million USD | -10.24% |
| 1995 | 709.03 Million USD | 27.27% |
| 1994 | 606.06 Million USD | 90.38% |
| 1993 | 356.1 Million USD | 70.55% |
| 1992 | 208.8 Million USD | 61.36% |
| 1991 | 129.4 Million USD | 96.36% |
| 1990 | 65.9 Million USD | 95.55% |
| 1989 | 33.7 Million USD | 5516.67% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 7.91 Billion USD | -75.39% |
| 2024 Q2 | 7.89 Billion USD | 316.4% |
| 2024 Q3 | 3.92 Billion USD | 26.84% |
| 2023 Q1 | 8.25 Billion USD | 4.89% |
| 2023 Q2 | 7.96 Billion USD | -3.57% |
| 2023 Q3 | 8.53 Billion USD | 7.2% |
| 2023 FY | - USD | 8.17% |
| 2023 Q4 | 7.48 Billion USD | -12.32% |
| 2022 FY | - USD | 20.43% |
| 2022 Q4 | 7.87 Billion USD | -5.03% |
| 2022 Q1 | 7.73 Billion USD | 22.59% |
| 2022 Q2 | 7.93 Billion USD | 2.53% |
| 2022 Q3 | 8.29 Billion USD | 4.49% |
| 2021 Q3 | 6.5 Billion USD | -3.67% |
| 2021 Q2 | 6.75 Billion USD | -9.88% |
| 2021 FY | - USD | 4.01% |
| 2021 Q1 | 7.49 Billion USD | 76.44% |
| 2021 Q4 | 6.31 Billion USD | -3.01% |
| 2020 FY | - USD | 6.2% |
| 2020 Q1 | 5.71 Billion USD | -1.62% |
| 2020 Q2 | 9.95 Billion USD | 74.12% |
| 2020 Q3 | 5.37 Billion USD | -46.07% |
| 2020 Q4 | 4.24 Billion USD | -20.88% |
| 2019 Q3 | 5.72 Billion USD | 6.02% |
| 2019 Q1 | 5.47 Billion USD | 6.56% |
| 2019 Q2 | 5.39 Billion USD | -1.33% |
| 2019 Q4 | 5.81 Billion USD | 1.57% |
| 2019 FY | - USD | 13.32% |
| 2018 Q2 | 4.8 Billion USD | 3.6% |
| 2018 Q3 | 5.2 Billion USD | 8.31% |
| 2018 Q4 | 5.13 Billion USD | -1.29% |
| 2018 Q1 | 4.63 Billion USD | 1.76% |
| 2018 FY | - USD | 13.28% |
| 2017 Q3 | 4.66 Billion USD | 8.84% |
| 2017 FY | - USD | 13.82% |
| 2017 Q2 | 4.28 Billion USD | 8.64% |
| 2017 Q1 | 3.94 Billion USD | 6.25% |
| 2017 Q4 | 4.55 Billion USD | -2.38% |
| 2016 FY | - USD | 20.62% |
| 2016 Q1 | 3.46 Billion USD | 17.28% |
| 2016 Q3 | 4.09 Billion USD | 10.26% |
| 2016 Q2 | 3.71 Billion USD | 7.28% |
| 2016 Q4 | 3.71 Billion USD | -9.3% |
| 2015 FY | - USD | 8.19% |
| 2015 Q4 | 2.95 Billion USD | -14.93% |
| 2015 Q1 | 3.01 Billion USD | -4.07% |
| 2015 Q2 | 3.27 Billion USD | 8.48% |
| 2015 Q3 | 3.47 Billion USD | 5.99% |
| 2014 Q2 | 2.91 Billion USD | 20.8% |
| 2014 FY | - USD | 6.86% |
| 2014 Q1 | 2.41 Billion USD | -13.85% |
| 2014 Q4 | 3.14 Billion USD | -3.97% |
| 2014 Q3 | 3.27 Billion USD | 12.35% |
| 2013 Q4 | 2.8 Billion USD | -5.97% |
| 2013 FY | - USD | 4.12% |
| 2013 Q3 | 2.98 Billion USD | 8.72% |
| 2013 Q2 | 2.74 Billion USD | 10.75% |
| 2013 Q1 | 2.47 Billion USD | 0.16% |
| 2012 Q1 | 2.61 Billion USD | 17.6% |
| 2012 FY | - USD | 10.17% |
| 2012 Q4 | 2.47 Billion USD | -15.58% |
| 2012 Q3 | 2.92 Billion USD | 14.69% |
| 2012 Q2 | 2.55 Billion USD | -2.33% |
| 2011 Q3 | 2.19 Billion USD | -0.68% |
| 2011 Q4 | 2.22 Billion USD | 1.28% |
| 2011 FY | - USD | 7.39% |
| 2011 Q1 | 2.3 Billion USD | 8.81% |
| 2011 Q2 | 2.2 Billion USD | -4.33% |
| 2010 Q3 | 2.25 Billion USD | 12.74% |
| 2010 Q2 | 2 Billion USD | -4.3% |
| 2010 Q4 | 2.12 Billion USD | -5.94% |
| 2010 Q1 | 2.09 Billion USD | 14.08% |
| 2010 FY | - USD | 21.47% |
| 2009 FY | - USD | 17.71% |
| 2009 Q1 | 1.9 Billion USD | 23.67% |
| 2009 Q4 | 1.83 Billion USD | -4.83% |
| 2009 Q3 | 1.92 Billion USD | 14.03% |
| 2009 Q2 | 1.68 Billion USD | -11.2% |
| 2008 FY | - USD | -27.77% |
| 2008 Q2 | 916 Million USD | -52.73% |
| 2008 Q3 | 1.85 Billion USD | 102.18% |
| 2008 Q1 | 1.93 Billion USD | -13.67% |
| 2008 Q4 | 1.53 Billion USD | -16.95% |
| 2007 FY | - USD | 27.45% |
| 2007 Q4 | 2.24 Billion USD | -4.75% |
| 2007 Q3 | 2.35 Billion USD | 3.83% |
| 2007 Q2 | 2.27 Billion USD | 28.03% |
| 2007 Q1 | 1.77 Billion USD | 37.76% |
| 2006 Q2 | 1.83 Billion USD | 12.58% |
| 2006 FY | - USD | 27.33% |
| 2006 Q1 | 1.63 Billion USD | 55.24% |
| 2006 Q4 | 1.28 Billion USD | -36.63% |
| 2006 Q3 | 2.03 Billion USD | 10.68% |
| 2005 Q2 | 1.37 Billion USD | 4.66% |
| 2005 FY | - USD | 30.34% |
| 2005 Q4 | 1.05 Billion USD | -27.03% |
| 2005 Q3 | 1.43 Billion USD | 5.04% |
| 2005 Q1 | 1.3 Billion USD | 44.48% |
| 2004 Q1 | 958 Million USD | 52.06% |
| 2004 Q3 | 1.19 Billion USD | 15.41% |
| 2004 Q2 | 1.03 Billion USD | 7.72% |
| 2004 FY | - USD | 37.29% |
| 2004 Q4 | 906 Million USD | -23.93% |
| 2003 FY | - USD | 21.96% |
| 2003 Q1 | 726 Million USD | 6.76% |
| 2003 Q2 | 783 Million USD | 7.85% |
| 2003 Q3 | 838 Million USD | 7.02% |
| 2003 Q4 | 887 Million USD | -24.82% |
| 2002 Q4 | 680 Million USD | 6.58% |
| 2002 Q1 | 538 Million USD | 9.57% |
| 2002 Q2 | 11.63 Billion USD | 2062.27% |
| 2002 Q3 | 638 Million USD | -94.52% |
| 2002 FY | - USD | 33.32% |
| 2001 Q3 | 463 Million USD | 3.35% |
| 2001 FY | - USD | 28.94% |
| 2001 Q4 | 491 Million USD | 6.05% |
| 2001 Q1 | 429 Million USD | 17.53% |
| 2001 Q2 | 448 Million USD | 4.43% |
| 2000 Q2 | 349 Million USD | 4.18% |
| 2000 Q4 | 392 Million USD | -1.62% |
| 2000 FY | - USD | 20.75% |
| 2000 Q1 | 335 Million USD | 101.22% |
| 2000 Q3 | 371 Million USD | 6.3% |
| 1999 Q2 | 9.54 Billion USD | 0.99% |
| 1999 FY | - USD | -26.18% |
| 1999 Q4 | -27.45 Billion USD | -385.11% |
| 1999 Q3 | 9.62 Billion USD | 0.86% |
| 1999 Q1 | 9.45 Billion USD | 139.03% |
| 1998 Q1 | 8.06 Billion USD | 149.93% |
| 1998 Q2 | 8.47 Billion USD | 14.06% |
| 1998 Q3 | 8.54 Billion USD | -7.05% |
| 1998 Q4 | -24.21 Billion USD | -383.26% |
| 1998 FY | - USD | 79.39% |
| 1997 Q1 | 5.55 Billion USD | 140.6% |
| 1997 Q3 | 5.76 Billion USD | 0.98% |
| 1997 FY | - USD | 14.66% |
| 1997 Q4 | -16.14 Billion USD | -379.98% |
| 1997 Q2 | 5.71 Billion USD | 2.75% |
| 1996 Q3 | 5.05 Billion USD | 2.54% |
| 1996 Q1 | 4.47 Billion USD | 176.25% |
| 1996 FY | - USD | -10.24% |
| 1996 Q4 | -13.7 Billion USD | -370.64% |
| 1996 Q2 | 4.91 Billion USD | 10.28% |
| 1995 Q2 | 2.19 Billion USD | 5.19% |
| 1995 Q4 | -5.86 Billion USD | -355.12% |
| 1995 Q1 | 2.08 Billion USD | 547.99% |
| 1995 FY | - USD | 27.27% |
| 1995 Q3 | 2.29 Billion USD | 4.9% |
| 1994 Q3 | 147.6 Million USD | -15.56% |
| 1994 Q4 | 285.66 Million USD | 117.92% |
| 1994 FY | - USD | 90.38% |
| 1994 Q1 | 88.1 Million USD | -52.56% |
| 1994 Q2 | 138.9 Million USD | 98.41% |
| 1993 FY | - USD | 70.55% |
| 1993 Q4 | 143.4 Million USD | 176.75% |
| 1993 Q3 | 67.1 Million USD | -8.83% |
| 1993 Q2 | 73.6 Million USD | 4.55% |
| 1993 Q1 | 70.4 Million USD | 13.73% |
| 1992 Q1 | 45.2 Million USD | 22.49% |
| 1992 FY | - USD | 61.36% |
| 1992 Q4 | 61.9 Million USD | 18.36% |
| 1992 Q2 | 49.4 Million USD | 9.29% |
| 1992 Q3 | 52.3 Million USD | 5.87% |
| 1991 FY | - USD | 96.36% |
| 1991 Q4 | 36.9 Million USD | 9.5% |
| 1991 Q2 | 31.5 Million USD | 14.96% |
| 1991 Q3 | 33.7 Million USD | 6.98% |
| 1991 Q1 | 27.4 Million USD | 42.71% |
| 1990 FY | - USD | 95.55% |
| 1990 Q3 | 17.1 Million USD | 8.92% |
| 1990 Q4 | 19.2 Million USD | 12.28% |
| 1990 Q2 | 15.7 Million USD | 12.95% |
| 1990 Q1 | 13.9 Million USD | 27.52% |
| 1989 Q4 | 10.9 Million USD | 23.86% |
| 1989 Q1 | 96 Million USD | 126.34% |
| 1989 Q2 | 7.4 Million USD | -92.29% |
| 1989 Q3 | 8.8 Million USD | 18.92% |
| 1989 FY | - USD | 51.12% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cigna Corporation | 9.98 Billion USD | -263.773% |
| Centene Corporation | 5.61 Billion USD | -546.902% |
| CVS Health Corporation | 18.17 Billion USD | -99.857% |
| Elevance Health Inc. | 10.49 Billion USD | -246.33% |
| Humana Inc. | 4.93 Billion USD | -636.917% |
| Molina Healthcare, Inc. | 1.74 Billion USD | -1983.142% |
| Oscar Health, Inc. | -212 Million USD | 17236.55% |